AgomAb Therapeutics AGMB
NASDAQ AGMB
$9.11 +0.38 (+4.35%)
At close: Oct 21, 2026 · 4:00 PM EDT

AgomAb Therapeutics NV (AGMB) Other Operating Expenses (2023 - 2025)

Updated

Agomab Therapeutics' Other Operating Expenses came in at $2.7 million for FY2025, up 75.7% from $1.54 million in FY2024.

Analysis

AgomAb Therapeutics NV (AGMB) Other Operating Expenses (2023 - 2025) Analysis & Trends

  • Per Business Quant, earlier years put Other Operating Expenses at $1.54 million in FY2024 (+16.8%) and $1.32 million in FY2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 698,426.11
Dec 31, 2024 224,405.03
Dec 31, 2023 131,264.67
API Access

AgomAb Therapeutics NV Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=AGMB&period=max&api_key=YOUR_API_KEY